gw420867x has been researched along with 5-ethyl-1-benzyloxymethyl-6-(phenylthio)uracil in 1 studies
Studies (gw420867x) | Trials (gw420867x) | Recent Studies (post-2010) (gw420867x) | Studies (5-ethyl-1-benzyloxymethyl-6-(phenylthio)uracil) | Trials (5-ethyl-1-benzyloxymethyl-6-(phenylthio)uracil) | Recent Studies (post-2010) (5-ethyl-1-benzyloxymethyl-6-(phenylthio)uracil) |
---|---|---|---|---|---|
17 | 5 | 2 | 9 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jorgensen, WL; Kroeger Smith, MB; Rizzo, RC; Smith, RH; Tirado-Rives, J; Udier-Blagović, M; Wang, DP; Watkins, EK | 1 |
1 other study(ies) available for gw420867x and 5-ethyl-1-benzyloxymethyl-6-(phenylthio)uracil
Article | Year |
---|---|
Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations.
Topics: Alkynes; Anilides; Benzoxazines; Computer Simulation; Cyclopropanes; HIV Reverse Transcriptase; Hydrogen Bonding; Models, Molecular; Monte Carlo Method; Nevirapine; Oxazines; Protein Binding; Quinoxalines; Regression Analysis; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Uracil | 2002 |